SCHEMBL10028079

SCHEMBL10028079

c1cc2ccc3oc4cccc5ccc6oc(c1)c2c3-c6c54

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HSD17B10 Q99714 5/20 0.48
TSHR P16473 4/20 0.48
HPGD P15428 4/20 0.48
CYP3A4 P08684 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP1A1 P04798 2/20 0.48
CYP1B1 Q16678 2/20 0.48
TYMS P04818 2/20 0.39
CA12 O43570 3/20 0.39
CA9 Q16790 3/20 0.39
CA1 P00915 2/20 0.39
CA3 P07451 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CA5A P35218 2/20 0.39
CA7 P43166 2/20 0.39
CA14 Q9ULX7 2/20 0.39
CA5B Q9Y2D0 2/20 0.39
CA13 Q8N1Q1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29737512 1.00 ALDH1A1 (0.48) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10028200 0.86 ALDH1A1 (0.36) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10028189 0.86 CYP1A2 (0.36) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10028186 0.86 ALDH1A1 (0.36) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL30352822 0.84 ALDH1A1 (0.59) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL6254645 0.84 ALDH1A1 (0.59) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10062248 0.83 ALDH1A1 (0.40) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10028190 0.83 PGR (0.37) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL17304507 0.83 ALDH1A1 (0.36) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10028194 0.83 ALDH1A1 (0.34) ALDH1A1HSD17B10TSHRHPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220123222-A1 Arylamine Compound and Use Thereof in Photoelectric Devices ZHEJIANG UNIVERSITY (CN) 2022-04-21 US disclosed
WO-2021135261-A1 AROMATIC AMINE COMPOUND AND APPLICATION THEREOF IN OPTOELECTRONIC DEVICE 浙江大学 2021-07-08 WO disclosed
US-10374170-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
US-9966543-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-08 US disclosed
US-9966543-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-08 US disclosed
US-20170288152-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR FILM, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR ELEMENT, AND MANUFACTURING METHOD THEREOF FUJIFILM CORPORATION (JP) 2017-10-05 US disclosed
US-20170288151-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM AND ORGANIC SEMICONDUCTOR ELEMENT FUJIFILM CORPORATION (JP) 2017-10-05 US disclosed
US-20170288152-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR FILM, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR ELEMENT, AND MANUFACTURING METHOD THEREOF FUJIFILM CORPORATION (JP) 2017-10-05 US disclosed
EP-3193383-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR FILM AND METHOD FOR MANUFACTURING SAME, AND ORGANIC SEMICONDUCTOR COMPOUND Fujifilm Corporation (JP) 2017-07-19 EP disclosed
US-20170098786-A1 COMPOSITION FOR FORMING ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR FILM AND METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR ELEMENT AND METHOD FOR MANUFACTURING SAME, AND ORGANIC SEMICONDUCTOR COMPOUND FUJIFILM CORPORATION (JP) 2017-04-06 US disclosed
US-8399288-B2 Semiconductor device, method of manufacturing the same, and method of forming multilayer semiconductor thin film SONY CORPORATION (JP) 2013-03-19 US disclosed
US-20120205628-A1 SEMICONDUCTING COMPOSITION XEROX CORPORATION (US) 2012-08-16 US disclosed
US-20120205628-A1 SEMICONDUCTING COMPOSITION XEROX CORPORATION (US) 2012-08-16 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20120025173-A1 SEMICONDUCTOR DEVICE, METHOD OF MANUFACTURING THE SAME, AND METHOD OF FORMING MULTILAYER SEMICONDUCTOR THIN FILM SONY CORPORATION (JP) 2012-02-02 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20090289248-A1 DIOXAANTHANTHRENE COMPOUND AND SEMICONDUCTOR DEVICE SONY CORPORATION (JP) 2009-11-26 US disclosed
WO-2008011964-A1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120205628-A1 SEMICONDUCTING COMPOSITION CCNY, ZYX, NR5A1 ALDH1A1 2378/4885HSD17B10 2850/4885TSHR 2707/4885
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 ALDH1A1 220/4885HSD17B10 2763/4885TSHR 4729/4885
US-10374170-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 ALDH1A1 1740/4885HSD17B10 4302/4885TSHR 4405/4885
US-20220123222-A1 Arylamine Compound and Use Thereof in Photoelectric Devices TYR, INMT, FTO ALDH1A1 1788/4885HSD17B10 4021/4885TSHR 4392/4885
US-20090289248-A1 DIOXAANTHANTHRENE COMPOUND AND SEMICONDUCTOR DEVICE DDT, DHX9, DHX29 ALDH1A1 600/4885HSD17B10 806/4885TSHR 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.